<?xml version="1.0"?>
<body status="ih"><p nid="t0:ih:1">HR 589 IH</p><p/><center><p nid="t0:ih:2">113th CONGRESS</p></center>
<p/><center><p nid="t0:ih:3">1st Session</p></center>
<p/><center><p nid="t0:ih:4">H. R. 589</p></center>
<p nid="t0:ih:5">To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.</p><p/><center><p nid="t0:ih:6">IN THE HOUSE OF REPRESENTATIVES</p></center>
<p/><h3 nid="t0:ih:7"><center><p nid="t0:ih:8">February 6, 2013</p></center></h3>
<p nid="t0:ih:9">Mr. YOUNG of Florida (for himself and Ms. MATSUI) introduced the following bill; which was referred to the Committee on Energy and Commerce</p><hr/><p/><center><p nid="t0:ih:10">A BILL</p></center>
<p nid="t0:ih:11">To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.</p><ul><p nid="t0:ih:12"><em>  Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</em></p></ul><p/><h3 nid="t0:ih:13">SECTION 1. AMENDMENT TO THE NATIONAL ORGAN TRANSPLANT ACT TO PREVENT THE SALE OF BONE MARROW AND UMBILICAL CORD BLOOD.</h3>
<ul><p nid="t0:ih:14">Paragraph 1 of section 301(c) of the National Organ Transplant Act (<usc-reference title="42" section="274e" paragraph="c">42 U.S.C. 274e(c)</usc-reference>) is amended--</p><ul><p nid="t0:ih:15">(1) by inserting &#x2018;(as defined in section 379A-1 of the Public Health Service Act (<usc-reference title="42" section="274l-1" paragraph="">42 U.S.C. 274l-1</usc-reference>))&#x2019; after &#x2018;bone marrow&#x2019;; and</p><p nid="t0:ih:16">(2) by inserting &#x2018;, a cord blood unit (as defined in section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (<usc-reference title="42" section="274k" paragraph="">42 U.S.C. 274k</usc-reference> note)),&#x2019; after &#x2018;skin or any subpart therof&#x2019;.</p></ul></ul></body>
